Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Citation
Government in Your Car
CEI General Counsel Sam Kazman discusses the unintended consequences of government mandates for auto manufacturers. CAFE fuel effciency standards result in smaller, lighter cars, which…
Comment
Response to Citizen Petition Requesting Certain Prescription Allergy Medication be OTC
Commenters believe that the FDCA, read as an integrated whole, generally leaves the determination whether prescription drug or OTC drug labeling should be proposed for…
Legal Brief
Memorandum Opinion in Association of Physicians and Surgeons vs US FDA
Comment
Comments Regarding the Constitutionality of FDA Treatment of Product Information
This request for comments represents a welcome departure from FDA’s prior treatment of First Amendment concerns in the context of product advertising, labeling, and promotions.
Comment
Comments on the ATF Proposed Rule Regarding Health Claims in Labeling Alcohol Beverages
ATF’s notice of proposed rulemaking seeks to prohibit what it deems misleading statements about the health benefits of alcohol consumption from appearing on alcoholic beverage…
Legal Brief